ArticleBMC cancer2026
Open versus laparoscopic adrenalectomy and comparison of laparoscopic approaches for adrenocortical carcinoma.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundComparative studies on different surgery approaches for adrenocortical carcinoma (ACC) remains controversial. This retrospective study aimed to compare the overall survival (OS), disease-free survival (DFS) of open versus laparoscopic adrenalectomy and different laparoscopic approaches in ACC.
methodsFrom 2000 to 2024, we retrospectively analyzed a total of 154 ACC patients with stage I-III who underwent either OA or LA. Propensity score matching (PSM) was performed to balance baseline characteristics between the OA and LA groups, as well as among subgroups within the LA group. The primary outcomes of the study were OS and DFS. Survival analyses were conducted using the Kaplan-Meier method, and the log-rank test was employed to compare survival curves. Univariate and multivariate Cox proportional hazards models were utilized to identify variables affecting OS and DFS.
resultsRegarding perioperative and survival outcomes, the LA group demonstrated significantly shorter operative times (unmatched cohort: p < 0.001; matched cohort: p = 0.001) and reduced lengths of hospital stay (unmatched cohort: p = 0.001; matched cohort: p = 0.017) compared to the OA group. There were no significant differences in the incidence of tumor rupture, mortality rate, OS, recurrence, or DFS. And in the comparison of retroperitoneal (RLA) and transabdominal laparoscopic adrenalectomy (TLA), RLA was superior to TLA in operative time, with no significant advantages observed in other outcomes. Long-term survival analyses revealed no significant differences in OS or DFS between the matched and unmatched OA and LA groups. Furthermore, the type of laparoscopic approach did not influence OS or DFS. Notably, T stage and tumor size emerged as significant predictors of poorer survival outcomes in both surgical cohorts.
conclusionFor localized ACC (stage I-III), LA and OA demonstrate comparable long-term oncological outcomes in terms of OS and DFS. Both TLA and RLA appear to be safe and effective surgical interventions for the management of localized ACC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.